ID	Description	NES	pvalue	p.adjust	GeneRatio	BgRatio	geneID	geneName	Count
KEGG_hsa01521	EGFR tyrosine kinase inhibitor resistance	-0.891933538577964	0.00311154640936145	0.0685976308402302	4/109	73/13177	3845/9470/2885/598	KRAS/EIF4E2/GRB2/BCL2L1	4
KEGG_hsa04910	Insulin signaling pathway	-0.708577219734352	0.00431707920271421	0.0790250689332424	5/109	129/13177	3845/90673/9470/3630/2885	KRAS/PPP1R3E/EIF4E2/INS/GRB2	5
KEGG_hsa04211	Longevity regulating pathway	-0.573729106498535	0.00582689846601884	0.0790250689332424	4/109	87/13177	3845/9470/10919/3630	KRAS/EIF4E2/EHMT2/INS	4
KEGG_hsa05160	Hepatitis C	-1.10493562314652	0.00704514394799376	0.0790250689332424	5/109	145/13177	3845/7534/8837/2885/7531	KRAS/YWHAZ/CFLAR/GRB2/YWHAE	5
KEGG_hsa05215	Prostate cancer	-0.696982293725696	0.00763993205486926	0.0790250689332424	4/109	94/13177	3845/2033/3630/2885	KRAS/EP300/INS/GRB2	4
KEGG_hsa05161	Hepatitis B	-0.869884040281422	0.0081001213476827	0.0790250689332424	5/109	150/13177	3845/2033/7534/1959/2885	KRAS/EP300/YWHAZ/EGR2/GRB2	5
KEGG_hsa04066	HIF-1 signaling pathway	-0.429030310531453	0.00914010835148031	0.0845017759204599	4/109	99/13177	3939/2033/9470/3630	LDHA/EP300/EIF4E2/INS	4
KEGG_hsa05225	Hepatocellular carcinoma	-1.10249111360595	0.00950539150841888	0.0846867414950869	5/109	156/13177	3845/196528/6598/2885/598	KRAS/ARID2/SMARCB1/GRB2/BCL2L1	5
KEGG_hsa04919	Thyroid hormone signaling pathway	-0.636530378907056	0.0126892031374016	0.0894331769317162	4/109	109/13177	3845/2033/5469/10025	KRAS/EP300/MED1/MED16	4
KEGG_hsa04722	Neurotrophin signaling pathway	-0.862919681783702	0.0139034488822557	0.0894331769317162	4/109	112/13177	3845/4794/2885/7531	KRAS/NFKBIE/GRB2/YWHAE	4
KEGG_hsa05211	Renal cell carcinoma	-0.651801311940068	0.0146257664594656	0.0894331769317162	3/109	62/13177	3845/2033/2885	KRAS/EP300/GRB2	3
KEGG_hsa04068	FoxO signaling pathway	-0.696982293725696	0.0184746046080185	0.0987839865794422	4/109	122/13177	3845/2033/3630/2885	KRAS/EP300/INS/GRB2	4
KEGG_hsa04210	Apoptosis	-0.837019506239707	0.0194881341724648	0.0987971546366267	4/109	124/13177	3845/4000/8837/598	KRAS/LMNA/CFLAR/BCL2L1	4
KEGG_hsa04917	Prolactin signaling pathway	-0.67212252020741	0.0201907613118864	0.0987971546366267	3/109	70/13177	3845/3630/2885	KRAS/INS/GRB2	3
KEGG_hsa04140	Autophagy	-0.845240229265406	0.0238831612634377	0.0987971546366267	4/109	132/13177	3845/8837/3630/598	KRAS/CFLAR/INS/BCL2L1	4
KEGG_hsa05220	Chronic myeloid leukemia	-0.90024507389563	0.0241825698123746	0.0987971546366267	3/109	75/13177	3845/2885/598	KRAS/GRB2/BCL2L1	3
KEGG_hsa04662	B cell receptor signaling pathway	-0.717653206073806	0.0250284678192736	0.100183783198377	3/109	76/13177	3845/4794/2885	KRAS/NFKBIE/GRB2	3
KEGG_hsa04150	mTOR signaling pathway	-0.688607626116913	0.0262886286777154	0.103778525882	4/109	136/13177	3845/9470/3630/2885	KRAS/EIF4E2/INS/GRB2	4
KEGG_hsa04110	Cell cycle	-0.687139429536237	0.0294951591611335	0.112855950775976	3/109	81/13177	2033/7534/7531	EP300/YWHAZ/YWHAE	3
KEGG_hsa03040	Spliceosome	-0.697905401399352	0.0320262261050454	0.112855950775976	2/109	34/13177	4116/7919	MAGOH/DDX39B	2
KEGG_hsa04960	Aldosterone-regulated sodium reabsorption	-0.416107910241027	0.0355849124898792	0.121702099279229	2/109	36/13177	3845/3630	KRAS/INS	2
KEGG_hsa01522	Endocrine resistance	-0.842103852375963	0.0429382535542591	0.128724931680446	3/109	94/13177	3845/5469/2885	KRAS/MED1/GRB2	3
KEGG_hsa04940	Type I diabetes mellitus	-0.297054057117991	0.0431323774776296	0.128768118594673	2/109	40/13177	3630/3107	INS/HLA-C	2
KEGG_hsa04114	Oocyte meiosis	-0.70746063780358	0.044079959979036	0.13132345665272	3/109	95/13177	7534/3630/7531	YWHAZ/INS/YWHAE	3
KEGG_hsa04660	T cell receptor signaling pathway	-0.717653206073806	0.045236769338651	0.13323292440112	3/109	96/13177	3845/4794/2885	KRAS/NFKBIE/GRB2	3
KEGG_hsa04621	NOD-like receptor signaling pathway	-0.816536969537366	0.0471222909542926	0.13323292440112	4/109	164/13177	4671/11035/598/7531	NAIP/RIPK3/BCL2L1/YWHAE	4
KEGG_hsa04931	Insulin resistance	-0.538081232637962	0.0512450673646267	0.1398746314924	3/109	101/13177	90673/133522/3630	PPP1R3E/PPARGC1B/INS	3
KEGG_hsa03015	mRNA surveillance pathway	-0.697905401399352	0.0665276050934685	0.154763081329449	2/109	51/13177	4116/7919	MAGOH/DDX39B	2
KEGG_hsa04650	Natural killer cell mediated cytotoxicity	-0.664339417599052	0.0671443171428044	0.155944580981586	3/109	113/13177	3845/3107/2885	KRAS/HLA-C/GRB2	3
KEGG_hsa04935	Growth hormone synthesis, secretion and action	-0.651801311940068	0.071432969878325	0.159585011580986	3/109	116/13177	3845/2033/2885	KRAS/EP300/GRB2	3
KEGG_hsa03013	Nucleocytoplasmic transport	-0.697905401399352	0.0782731701364113	0.166315408340137	2/109	56/13177	4116/7919	MAGOH/DDX39B	2
KEGG_hsa05213	Endometrial cancer	-0.637365396169432	0.0782731701364113	0.166315408340137	2/109	56/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa04145	Phagosome	-0.62330980758525	0.0803694102851785	0.167397332759681	3/109	122/13177	83547/9146/3107	RILP/HGS/HLA-C	3
KEGG_hsa04213	Longevity regulating pathway	-0.416107910241027	0.0831412080474655	0.171238829117574	2/109	58/13177	3845/3630	KRAS/INS	2
KEGG_hsa00430	Taurine and hypotaurine metabolism	-0.426878467394362	0.0873521172958456	0.171238829117574	1/109	11/13177	2678	GGT1	1
KEGG_hsa04137	Mitophagy	-0.6843980601985	0.093144373638559	0.178716073456153	2/109	62/13177	3845/598	KRAS/BCL2L1	2
KEGG_hsa03430	Mismatch repair	-0.23801248091846	0.0949078380321932	0.178716073456153	1/109	12/13177	5395	PMS2	1
KEGG_hsa04612	Antigen processing and presentation	-0.370793206298234	0.0956977508682001	0.179261277116511	2/109	63/13177	5720/3107	PSME1/HLA-C	2
KEGG_hsa05221	Acute myeloid leukemia	-0.637365396169432	0.0956977508682001	0.179261277116511	2/109	63/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa04664	Fc epsilon RI signaling pathway	-0.637365396169432	0.0982711420119104	0.183601755545069	2/109	64/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa04720	Long-term potentiation	-0.39220856348545	0.100864048861609	0.185984102419293	2/109	65/13177	3845/2033	KRAS/EP300	2
KEGG_hsa05230	Central carbon metabolism in cancer	-0.428650730967991	0.106106450445988	0.191499425049245	2/109	67/13177	3939/3845	LDHA/KRAS	2
KEGG_hsa03050	Proteasome	-0.299321066491235	0.109833831670546	0.19197296552937	1/109	14/13177	5720	PSME1	1
KEGG_hsa04072	Phospholipase D signaling pathway	-0.67212252020741	0.10985194119615	0.19197296552937	3/109	140/13177	3845/3630/2885	KRAS/INS/GRB2	3
KEGG_hsa05223	Non-small cell lung cancer	-0.637365396169432	0.114104348653383	0.196438502905578	2/109	70/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa05212	Pancreatic cancer	-0.6843980601985	0.11952038255174	0.199618541021729	2/109	72/13177	3845/598	KRAS/BCL2L1	2
KEGG_hsa05214	Glioma	-0.637365396169432	0.122252272070307	0.202762823637837	2/109	73/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa04630	JAK-STAT signaling pathway	-0.786477500791962	0.125950719950647	0.204866494539475	3/109	149/13177	2033/2885/598	EP300/GRB2/BCL2L1	3
KEGG_hsa04914	Progesterone-mediated oocyte maturation	-0.416107910241027	0.127761594918828	0.207576378139093	2/109	75/13177	3845/3630	KRAS/INS	2
KEGG_hsa04260	Cardiac muscle contraction	-0.579576883199307	0.136133015951852	0.212742312274065	2/109	78/13177	1337/7139	COX6A1/TNNT2	2
KEGG_hsa04012	ErbB signaling pathway	-0.637365396169432	0.141780730093169	0.216370379364762	2/109	80/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa04540	Gap junction	-0.637365396169432	0.141780730093169	0.216370379364762	2/109	80/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa05210	Colorectal cancer	-0.637365396169432	0.144623402774993	0.218297550902867	2/109	81/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa03008	Ribosome biogenesis in eukaryotes	-0.27860829064328	0.146090266096196	0.218297550902867	1/109	19/13177	138716	RPP25L	1
KEGG_hsa04350	TGF-beta signaling pathway	-0.241282124962653	0.153221977843951	0.224966285092604	2/109	84/13177	2033/64750	EP300/SMURF2	2
KEGG_hsa05235	PD-L1 expression and PD-1 checkpoint pathway in cancer	-0.469655594769655	0.159009347539814	0.22976722609639	2/109	86/13177	3845/4794	KRAS/NFKBIE	2
KEGG_hsa05410	Hypertrophic cardiomyopathy	-0.352685178985152	0.167765500424162	0.237088720027441	2/109	89/13177	4000/7139	LMNA/TNNT2	2
KEGG_hsa04912	GnRH signaling pathway	-0.637365396169432	0.170702815202276	0.240528155540671	2/109	90/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa05231	Choline metabolism in cancer	-0.637365396169432	0.173648848038526	0.241196749091117	2/109	91/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa05414	Dilated cardiomyopathy	-0.352685178985152	0.17956570973767	0.24828094378136	2/109	93/13177	4000/7139	LMNA/TNNT2	2
KEGG_hsa05167	Kaposi sarcoma-associated herpesvirus infection	-0.45588673033174	0.182797541822474	0.250668782231201	3/109	178/13177	3845/2033/3107	KRAS/EP300/HLA-C	3
KEGG_hsa04064	NF-kappa B signaling pathway	-0.699193258778171	0.185513418320002	0.253949612017707	2/109	95/13177	8837/598	CFLAR/BCL2L1	2
KEGG_hsa04922	Glucagon signaling pathway	-0.294851074797226	0.191489383866379	0.258384451111602	2/109	97/13177	3939/2033	LDHA/EP300	2
KEGG_hsa00563	Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	-0.160267314377811	0.194403416053418	0.25890343420497	1/109	26/13177	65258	MPPE1	1
KEGG_hsa04950	Maturity onset diabetes of the young	-0.202021675814241	0.194403416053418	0.25890343420497	1/109	26/13177	3630	INS	1
KEGG_hsa04916	Melanogenesis	-0.39220856348545	0.200500833914072	0.264356260043553	2/109	100/13177	3845/2033	KRAS/EP300	2
KEGG_hsa04215	Apoptosis	-0.556032651065573	0.201080476934734	0.264356260043553	1/109	27/13177	598	BCL2L1	1
KEGG_hsa04625	C-type lectin receptor signaling pathway	-0.367102533459975	0.206536602150342	0.268626325381841	2/109	102/13177	3845/1959	KRAS/EGR2	2
KEGG_hsa05034	Alcoholism	-0.637365396169432	0.206536602150342	0.268626325381841	2/109	102/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa00513	Various types of N-glycan biosynthesis	-0.140916201016266	0.227244782774523	0.286404374420309	1/109	31/13177	64377	CHST8	1
KEGG_hsa04120	Ubiquitin mediated proteolysis	-0.305758901601064	0.227802833828791	0.286603565299963	2/109	109/13177	4591/64750	TRIM37/SMURF2	2
KEGG_hsa04668	TNF signaling pathway	-0.412198212382546	0.227802833828791	0.286603565299963	2/109	109/13177	11035/8837	RIPK3/CFLAR	2
KEGG_hsa00640	Propanoate metabolism	-0.218572026986877	0.246309172527284	0.304539296144606	1/109	34/13177	3939	LDHA	1
KEGG_hsa05216	Thyroid cancer	-0.347036003483972	0.252559823078492	0.309596429830179	1/109	35/13177	3845	KRAS	1
KEGG_hsa05330	Allograft rejection	-0.189943502480132	0.252559823078492	0.309596429830179	1/109	35/13177	3107	HLA-C	1
KEGG_hsa04217	Necroptosis	-0.412198212382546	0.267630120264979	0.323367590505662	2/109	122/13177	11035/8837	RIPK3/CFLAR	2
KEGG_hsa05219	Bladder cancer	-0.347036003483972	0.27100524003553	0.325251682555205	1/109	38/13177	3845	KRAS	1
KEGG_hsa05332	Graft-versus-host disease	-0.189943502480132	0.27100524003553	0.325251682555205	1/109	38/13177	3107	HLA-C	1
KEGG_hsa04926	Relaxin signaling pathway	-0.637365396169432	0.279907465432292	0.333977850095316	2/109	126/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa03460	Fanconi anemia pathway	-0.23801248091846	0.283050879645525	0.334387395327319	1/109	40/13177	5395	PMS2	1
KEGG_hsa04623	Cytosolic DNA-sensing pathway	-0.177340416993911	0.288999532619464	0.339177993647578	1/109	41/13177	11035	RIPK3	1
KEGG_hsa04915	Estrogen signaling pathway	-0.637365396169432	0.295234553529335	0.344520452123402	2/109	131/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa04550	Signaling pathways regulating pluripotency of stem cells	-0.637365396169432	0.310517958490056	0.358604843553044	2/109	136/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa00270	Cysteine and methionine metabolism	-0.218572026986877	0.312309033324633	0.358604843553044	1/109	45/13177	3939	LDHA	1
KEGG_hsa04930	Type II diabetes mellitus	-0.202021675814241	0.312309033324633	0.358604843553044	1/109	45/13177	3630	INS	1
KEGG_hsa05320	Autoimmune thyroid disease	-0.189943502480132	0.312309033324633	0.358604843553044	1/109	45/13177	3107	HLA-C	1
KEGG_hsa00620	Pyruvate metabolism	-0.218572026986877	0.318017098765359	0.363411883995821	1/109	46/13177	3939	LDHA	1
KEGG_hsa04932	Non-alcoholic fatty liver disease	-0.522251995975311	0.325736019685511	0.370754341707179	2/109	141/13177	1337/3630	COX6A1/INS	2
KEGG_hsa00480	Glutathione metabolism	-0.426878467394362	0.329292768950015	0.373320045811211	1/109	48/13177	2678	GGT1	1
KEGG_hsa05224	Breast cancer	-0.637365396169432	0.331800441760462	0.375568746479259	2/109	143/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa05226	Gastric cancer	-0.637365396169432	0.331800441760462	0.375568746479259	2/109	143/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa04218	Cellular senescence	-0.40695436653318	0.337850019107023	0.380612482217267	2/109	145/13177	3845/3107	KRAS/HLA-C	2
KEGG_hsa04390	Hippo signaling pathway	-0.678925814969798	0.337850019107023	0.380612482217267	2/109	145/13177	7534/7531	YWHAZ/YWHAE	2
KEGG_hsa03018	RNA degradation	-0.289250683882955	0.340383693387628	0.382264759110087	1/109	50/13177	29883	CNOT7	1
KEGG_hsa04913	Ovarian steroidogenesis	-0.202021675814241	0.340383693387628	0.382264759110087	1/109	50/13177	3630	INS	1
KEGG_hsa05134	Legionellosis	-0.299556890845818	0.340383693387628	0.382264759110087	1/109	50/13177	4671	NAIP	1
KEGG_hsa04340	Hedgehog signaling pathway	-0.147887373908362	0.351292871465279	0.392976334746093	1/109	52/13177	64750	SMURF2	1
KEGG_hsa04923	Regulation of lipolysis in adipocytes	-0.202021675814241	0.362023254322125	0.402466503835225	1/109	54/13177	3630	INS	1
KEGG_hsa00590	Arachidonic acid metabolism	-0.426878467394362	0.367322306770413	0.407094250272237	1/109	55/13177	2678	GGT1	1
KEGG_hsa04370	VEGF signaling pathway	-0.347036003483972	0.372577745618304	0.411011477652833	1/109	56/13177	3845	KRAS	1
KEGG_hsa05416	Viral myocarditis	-0.189943502480132	0.372577745618304	0.411011477652833	1/109	56/13177	3107	HLA-C	1
KEGG_hsa00310	Lysine degradation	-0.293957558885685	0.377789926528876	0.415163316499907	1/109	57/13177	10919	EHMT2	1
KEGG_hsa04330	Notch signaling pathway	-0.170486298707953	0.377789926528876	0.415163316499907	1/109	57/13177	2033	EP300	1
KEGG_hsa04730	Long-term depression	-0.347036003483972	0.377789926528876	0.415163316499907	1/109	57/13177	3845	KRAS	1
KEGG_hsa05202	Transcriptional misregulation in cancer	-0.544890177878853	0.385582483050375	0.422754168485989	2/109	161/13177	6756/598	SSX1/BCL2L1	2
KEGG_hsa00010	Glycolysis / Gluconeogenesis	-0.218572026986877	0.388085922845881	0.424848836851144	1/109	59/13177	3939	LDHA	1
KEGG_hsa01524	Platinum drug resistance	-0.556032651065573	0.408174153262809	0.442780894493267	1/109	63/13177	598	BCL2L1	1
KEGG_hsa04520	Adherens junction	-0.170486298707953	0.408174153262809	0.442780894493267	1/109	63/13177	2033	EP300	1
KEGG_hsa04929	GnRH secretion	-0.347036003483972	0.408174153262809	0.442780894493267	1/109	63/13177	3845	KRAS	1
KEGG_hsa04115	p53 signaling pathway	-0.556032651065573	0.417971829926645	0.448990728849237	1/109	65/13177	598	BCL2L1	1
KEGG_hsa04920	Adipocytokine signaling pathway	-0.272678269153338	0.427608769697057	0.458655214802307	1/109	67/13177	4794	NFKBIE	1
KEGG_hsa04062	Chemokine signaling pathway	-0.637365396169432	0.428965790366221	0.459766624977408	2/109	176/13177	3845/2885	KRAS/GRB2	2
KEGG_hsa05218	Melanoma	-0.347036003483972	0.441768502018776	0.471724488370273	1/109	70/13177	3845	KRAS	1
KEGG_hsa05130	Pathogenic Escherichia coli infection	-0.463411012423306	0.443076274905221	0.472768653714952	2/109	181/13177	4671/4627	NAIP/MYH9	2
KEGG_hsa05412	Arrhythmogenic right ventricular cardiomyopathy	-0.187708565692794	0.464600791930429	0.492800099804815	1/109	75/13177	4000	LMNA	1
KEGG_hsa04146	Peroxisome	-0.1363955292615	0.490780985251941	0.516744417241758	1/109	81/13177	5190	PEX6	1
KEGG_hsa04727	GABAergic synapse	-0.20067074294621	0.5033913275057	0.529244146966741	1/109	84/13177	9001	HAP1	1
KEGG_hsa04911	Insulin secretion	-0.202021675814241	0.51162581558838	0.536327574058631	1/109	86/13177	3630	INS	1
KEGG_hsa05222	Small cell lung cancer	-0.556032651065573	0.523724535757049	0.547808218788213	1/109	89/13177	598	BCL2L1	1
KEGG_hsa00190	Oxidative phosphorylation	-0.487093964292116	0.527691071943058	0.550350295556333	1/109	90/13177	1337	COX6A1	1
KEGG_hsa04658	Th1 and Th2 cell differentiation	-0.272678269153338	0.527691071943058	0.550350295556333	1/109	90/13177	4794	NFKBIE	1
KEGG_hsa04933	AGE-RAGE signaling pathway in diabetic complications	-0.347036003483972	0.550812173725042	0.571552385914544	1/109	96/13177	3845	KRAS	1
KEGG_hsa05142	Chagas disease	-0.366558385051303	0.561948548574646	0.581844125800194	1/109	99/13177	8837	CFLAR	1
KEGG_hsa04659	Th17 cell differentiation	-0.272678269153338	0.579904414244756	0.59827431649585	1/109	104/13177	4794	NFKBIE	1
KEGG_hsa05145	Toxoplasmosis	-0.556032651065573	0.583407085310871	0.601454930396028	1/109	105/13177	598	BCL2L1	1
KEGG_hsa04725	Cholinergic synapse	-0.347036003483972	0.593742411147235	0.610791726614493	1/109	108/13177	3845	KRAS	1
KEGG_hsa04726	Serotonergic synapse	-0.347036003483972	0.59713074056685	0.613836693853871	1/109	109/13177	3845	KRAS	1
KEGG_hsa04152	AMPK signaling pathway	-0.202021675814241	0.607128627839223	0.623220145912326	1/109	112/13177	3630	INS	1
KEGG_hsa04071	Sphingolipid signaling pathway	-0.347036003483972	0.613656905056784	0.62947054040542	1/109	114/13177	3845	KRAS	1
KEGG_hsa04380	Osteoclast differentiation	-0.493972678814494	0.623248306778201	0.637483814142157	1/109	117/13177	2885	GRB2	1
KEGG_hsa04270	Vascular smooth muscle contraction	-0.311917605986011	0.64768723015415	0.661536565082607	1/109	125/13177	4627	MYH9	1
KEGG_hsa05162	Measles	-0.556032651065573	0.64768723015415	0.661536565082607	1/109	125/13177	598	BCL2L1	1
KEGG_hsa04371	Apelin signaling pathway	-0.347036003483972	0.65931089338655	0.671971913387572	1/109	129/13177	3845	KRAS	1
KEGG_hsa04514	Cell adhesion molecules	-0.189943502480132	0.673307422762944	0.682837605675371	1/109	134/13177	3107	HLA-C	1
KEGG_hsa04261	Adrenergic signaling in cardiomyocytes	-0.277662317990468	0.689352952208362	0.696645120250058	1/109	140/13177	7139	TNNT2	1
KEGG_hsa04921	Oxytocin signaling pathway	-0.347036003483972	0.699613606426323	0.70651606625012	1/109	144/13177	3845	KRAS	1
KEGG_hsa04530	Tight junction	-0.311917605986011	0.71913810786394	0.725211054587633	1/109	152/13177	4627	MYH9	1
KEGG_hsa04310	Wnt signaling pathway	-0.170486298707953	0.723819415342583	0.728394116703596	1/109	154/13177	2033	EP300	1
KEGG_hsa05164	Influenza A	-0.170486298707953	0.723819415342583	0.728394116703596	1/109	154/13177	2033	EP300	1
KEGG_hsa04022	cGMP-PKG signaling pathway	-0.202021675814241	0.730696793363782	0.734283664018443	1/109	157/13177	3630	INS	1
KEGG_hsa05152	Tuberculosis	-0.170486298707953	0.739603332278761	0.74271308700453	1/109	161/13177	2033	EP300	1
KEGG_hsa04360	Axon guidance	-0.347036003483972	0.764608890776257	0.766212965372291	1/109	173/13177	3845	KRAS	1
